BioSpace News Archive

Biotech Bay

Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will provide a corporate update at the Oppenheimer 34th Annual Healthcare Lifesciences Conference on Wednesday, February 14 at 2:00 pm ET.

February 7, 2024
·
1 min read
BioMidwest

ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study

Zivo Bioscience, Inc. announces additional findings from its 42-day coccidiosis challenge study that demonstrate the product’s positive impact on the cost of broiler production as an alternative to commonly-used antibiotics.

February 7, 2024
·
5 min read
Drug Development

Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine

Johnson & Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for JNJ-2113.

February 7, 2024
·
16 min read